Reports for Debiopharm Innovation Fund SA
Credit rating information
Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.Find out more
Economic information
Comprehensive information about the economic situation of a company.Find out more
Payment collection information
Overview of current and past debt enforcement proceedings.Find out more
Shareholder Information
Find out which national and international companies the stock corporation you are interested in also holds shares in.Find out more
Company dossier as PDF
Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.Retrieve company dossier
About Debiopharm Innovation Fund SA
- Debiopharm Innovation Fund SA is active in the industry «Services regarding management consulting» and is currently active. The legal headquarters are in Lausanne.
- The company was founded on 22.10.2004 and has 7 persons in its management.
- All past changes can be viewed and saved as a PDF under the section «Notifications». The last change in the commercial register was made on 10.06.2025.
- The company is registered in the commercial register VD under the UID CHE-112.050.229.
- On the same address there are 2 other active companies registered. These include: Impact Healthcare SA, Next Immobilier SA.
Management (7)
newest board members
Thierry Mauvernay,
Nadine Thérèse Claire Caillé-Mauvernay,
Bertrand Ducrey
newest authorized signatories
Marc Cikès,
Pierre Jullian-Gaufres,
Vanessa Currat,
Thierry Mauvernay,
Nadine Thérèse Claire Caillé-Mauvernay
Commercial register information
Entry in the commercial register
22.10.2004
Legal form
Company limited by shares (AG)
Legal headquarters of the company
Lausanne
Commercial Registry Office
VD
Commercial register number
CH-550.1.042.160-6
UID/VAT
CHE-112.050.229
CHE-116.301.703 VAT
Sector
Services regarding management consulting
Purpose (Original language)
La société a pour but, dans le strict respect des règles relatives à l'acquisition d'immeubles par des personnes à l'étranger: la promotion de la création de sociétés ou autres entités légales, actives dans le domaine médical et pharmaceutique, et le développement d'innovations thérapeutiques, notamment par l'acquisition, la gestion et l'administration de toute participation dans des sociétés ou entreprises suisses ou étrangères, ainsi que par le soutien des projets de financement de telles sociétés ou entreprises; la création ou la participation à la création d'un pool d'excellence dans le domaine thérapeutique dans l'arc lémanique (cf. statuts pour but complet).
Auditor
Current auditor (1)
| Name | City | Since | Until | |
|---|---|---|---|---|
| BDO SA | Epalinges | 19.07.2018 | ||
Former auditor (4)
| Name | City | Since | Until | |
|---|---|---|---|---|
| FORVIS MAZARS SA | Lausanne | 01.03.2018 | 18.07.2018 | |
| Ametis Révision Sàrl succursale de Fribourg | Fribourg | 29.06.2015 | 28.02.2018 | |
| Fiduciaire Favre Révision SA | Lausanne | 16.07.2008 | 28.06.2015 | |
Other company names
Past and translated company names
- Debiopharm Diagnostics SA
- Debioinnovation SA
Branches (0)
Ownership structure
Holdings
Newest SOGC notifications: Debiopharm Innovation Fund SA
The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications
Publication number: HR02-1006351822, Commercial Registry Office Vaud, (550)
Debiopharm Innovation Fund SA, à Lausanne, CHE-112.050.229 (FOSC du 24.09.2024, p. 0/1006137053). L'autre adresse, Case Postale 435, 1001 Lausanne, est radiée.
Publication number: HR02-1006137053, Commercial Registry Office Vaud, (550)
Debiopharm Innovation Fund SA, à Lausanne, CHE-112.050.229 (FOSC du 25.04.2024, p. 0/1006018130). Statuts modifiés le 10.09.2024.
Communications aux actionnaires:
par courrier ou par courriel s'ils sont tous connus, sinon par publication dans la Feuille officielle suisse du commerce.
Publication number: HR02-1006018130, Commercial Registry Office Vaud, (550)
Debiopharm Innovation Fund SA, à Lausanne, CHE-112.050.229 (FOSC du 19.04.2024, p. 0/1006013631).
Rectificatif:
l'inscription n° 6662 du 26.03.2024 (FOSC du 02.04.2024, p.1005998625) est rectifiée en ce sens que la nouvelle autre adresse est Case Postale 435, 1001 Lausanne et non CP 435, 1001 Lausanne.
Hit list
Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.